---
figid: PMC9662902__3546fig2
pmcid: PMC9662902
image_filename: 3546fig2.jpg
figure_link: /pmc/articles/PMC9662902/figure/fig2/
number: Figure 2
figure_title: ''
caption: HRR pathway (HRR)â€“centric subtyping of high-grade serous carcinoma. A, HRR-centric
  classification taxonomy. B, OS profile of HRR-centric subtypes. C, Chemosensitivity
  of HRR-centric subtypes at first-line treatment (left) and treatment for disease
  relapse (right) as determined by CA125 tumor marker (top) and radiology (bottom).
  BRCA2m, BRCA2 mutant; BRCA1m, BRCA1 mutant; EMSY-overxp; overexpression of EMSY;
  CCNE1g, gain of CCNE1; HRRwt, non-CCNE1g HRR wild-type.
article_title: Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables
  High-Resolution Patient Stratification.
citation: Robert L. Hollis, et al. Clin Cancer Res. 2022 Aug 15;28(16):3546-3556.
year: '2022'

doi: 10.1158/1078-0432.CCR-22-0368
journal_title: Clinical Cancer Research
journal_nlm_ta: Clin Cancer Res
publisher_name: American Association for Cancer Research

keywords:
---
